CAS 313348-27-5
:Regadenoson
Description:
Regadenoson is a pharmacological agent primarily used as a coronary vasodilator in medical imaging, particularly in stress testing for patients unable to undergo traditional exercise-based stress tests. It is a selective adenosine A2A receptor agonist, which means it binds to and activates these specific receptors, leading to vasodilation and increased blood flow in the coronary arteries. Regadenoson is characterized by its rapid onset of action and a relatively short half-life, making it suitable for use in clinical settings where quick diagnostic results are needed. The substance is typically administered intravenously and is known for its favorable safety profile, with fewer side effects compared to other stress agents. Its chemical structure includes a purine base, which is a common feature among adenosine derivatives. Regadenoson is marketed under various brand names and is an important tool in non-invasive cardiology for assessing myocardial perfusion.
Formula:C15H18N8O5
InChI:InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1
InChI key:InChIKey=LZPZPHGJDAGEJZ-AKAIJSEGSA-N
SMILES:NC1=C2C(N(C=N2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)=NC(=N1)N4C=C(C(NC)=O)C=N4
Synonyms:- 2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]adenosine
- 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine
- 6-Amino-2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]purine-9-yl-beta-D-ribofuranoside
- Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-
- Cv 3146
- Cvt-3146
- Lexiscan
- Nqz-021
- Rapiscan
- Regadenoson
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
1-(6-Amino-9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)-9H-Purin-2-Yl)-N-Methyl-1H-Pyrazole-4-Carboxamide
CAS:1-(6-Amino-9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)-9H-Purin-2-Yl)-N-Methyl-1H-Pyrazole-4-CarboxamidePurity:99%Molecular weight:390.35g/molRegadenoson
CAS:<p>Regadenoson (CVT-3146) is a selective A2A receptor agonist that increases coronary blood flow with a longer half-life than adenosine.</p>Formula:C15H18N8O5Purity:99.57% - 99.81%Color and Shape:Off-White SolidMolecular weight:390.35Regadenoson
CAS:Controlled Product<p>Applications Regadenoson is a selective and potent A2A adenosine receptor agonist (1). The adenosine A2A receptor is a G-protein-coupled receptor and a key therapeutic target for oncologic, inflammatory, Parkinson's and cardiovascular diseases (2). In rodent studies, it has been shown that co-administration of Regadenoson with Temozolomide (T017775) can increase Temozolomide concentration in the brain (3).<br>References (1) Gao, Z., et al.: J Pharmacol Exp Ther. 298, 209 (2001) (2) Yuan, G., et al.: Expert Opin Drug Discov. 10, 63 (2015) (3) Jackson, S., et al.: J Neurooncol. 126, 433 (2016)<br></p>Formula:C15H18N8O5Color and Shape:Off WhiteMolecular weight:390.35Regadenoson
CAS:<p>Adenosine-A2A receptor agonist</p>Formula:C15H18N8O5Purity:Min. 95%Color and Shape:White PowderMolecular weight:390.36 g/molRegadenoson-d3
CAS:Controlled Product<p>Applications A selective A2A adenosine receptor agonist in myocardial imaging.<br>References Palle, V.P., et al.: J. A. Drug Dev. Res., 50, 64 (2000), Gordi, T., et al.: J. Clin. Pharmacol., 47, 825 (2007), Zhao, G., et al.: J. Cardiovas. Pharmacol., 52, 467 (2008), Botvinick, E., et al.: J. Nuc. Med. Technol., 37, 14 (2009),<br></p>Formula:C15H15D3N8O5Color and Shape:NeatMolecular weight:393.37
